Open Access

Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature

  • Authors:
    • Abdulrahman Al‑Ghabban
    • Aisha Al‑Shibany
    • Khadija Al‑Shangiti
    • Mohamed Aseafan
    • Kousay Latif
    • Taher Al‑Tweigeri
  • View Affiliations

  • Published online on: April 12, 2021     https://doi.org/10.3892/wasj.2021.99
  • Article Number: 28
  • Copyright : © Al‑Ghabban et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cyclin‑dependent kinase 4/6 (CDK 4/6) inhibitors have been a major addition to the treatment of hormone receptor‑positive, human epidermal growth factor receptor 2 (HER2)‑negative breast cancer in the metastatic setting and currently in the adjuvant setting with promising results. However, rare yet potentially fatal side‑effects such as interstitial lung disease (ILD)/pneumonitis has been linked to the use of these drugs. The present study describes the case of a female patient with locally advance hormone receptor‑positive, HER2‑negative breast cancer who developed abemaciclib‑induced pneumonitis in the adjuvant setting (monarchE clinical trial). The patient was diagnosed based on presenting with symptoms of cough and shortness of breath, and by a computerized tomography scan after ruling out other causes. The patient exhibited the resolution of her symptoms completely following the discontinuation of abemaciclib treatment.
View Figures
View References

Related Articles

Journal Cover

May-June 2021
Volume 3 Issue 3

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Al‑Ghabban A, Al‑Shibany A, Al‑Shangiti K, Aseafan M, Latif K and Al‑Tweigeri T: Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature. World Acad Sci J 3: 28, 2021
APA
Al‑Ghabban, A., Al‑Shibany, A., Al‑Shangiti, K., Aseafan, M., Latif, K., & Al‑Tweigeri, T. (2021). Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature. World Academy of Sciences Journal, 3, 28. https://doi.org/10.3892/wasj.2021.99
MLA
Al‑Ghabban, A., Al‑Shibany, A., Al‑Shangiti, K., Aseafan, M., Latif, K., Al‑Tweigeri, T."Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature". World Academy of Sciences Journal 3.3 (2021): 28.
Chicago
Al‑Ghabban, A., Al‑Shibany, A., Al‑Shangiti, K., Aseafan, M., Latif, K., Al‑Tweigeri, T."Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature". World Academy of Sciences Journal 3, no. 3 (2021): 28. https://doi.org/10.3892/wasj.2021.99